Literature DB >> 21153151

Functional, long-term human theca and granulosa cell cultures from polycystic ovaries.

J M McAllister1.   

Abstract

Reproducible culture conditions for obtaining large numbers of functional PCOS theca interna and granulosalutein cells will be indispensable in studies focussing on the molecular basis for androgen overproduction by ovarian cells of patients with polycystic ovarian syndrome (PCOS). The objective of the present study was to determine if granuiosa and theca interna cells obtained from ovarian follicles of patients with PCOS could be passaged with maintenance of inducible steroidogenic activity. PCOS theca interna and granuiosa cells were obtained from individual follicles of polycystic ovaries containing multiple cystic follicles with characteristic hypertrophied theca interna. Utilizing conditions for growing normal ovarian cells, both cell types were passaged successively and conditions for cell freezing, storing and thawing were established. In granulosa-lutein cultures grown and passed for successive passages, and transferred into serum-free medium, forskolin stimulated aromatase activity increased 3-10-fold over control non-stimulated values. Concurrent treatment with IGF-I (50 ng/mL) enhanced forskolin-stimulated aromatase activity in PCOS granulosa-lutein cultures. In passaged PCOS theca interna cells, forskolinstimulated 17α-hydroxyprogesterone production was increased 4-25-fold over control values. Treatment of PCOS theca interna cells with insulin (50 ng/mL) enhanced forskolin-stimulated 17α-hydroxyprogesterone biosynthesis. The effects of various growth factors and phorbol esters on 17α-hydroxylase activity in cultured PCOS theca interna cells was also investigated. Treatment of PCOS theca cells with EGF, FGF, TGFβ and TPA resulted in the inhibition of forskolin-stimulated 17α-hydroxyprogesterone production. These data suggest that PCOS theca interna and granuiosa cells respond to insulin and to the growth factors similarly to cells obtained from normal cycling ovaries.

Entities:  

Year:  1995        PMID: 21153151     DOI: 10.1007/BF02990066

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  21 in total

Review 1.  STEROID SECRETIONS OF THE NORMAL AND POLYCYSTIC OVARY.

Authors:  V B MAHESH; R B GREENBLATT
Journal:  Recent Prog Horm Res       Date:  1964

2.  The polycystic ovary. I. Clinical and histologic features.

Authors:  J W GOLDZIEHER; J A GREEN
Journal:  J Clin Endocrinol Metab       Date:  1962-03       Impact factor: 5.958

Review 3.  Polycystic ovary syndrome: a changing perspective.

Authors:  S Franks
Journal:  Clin Endocrinol (Oxf)       Date:  1989-07       Impact factor: 3.478

Review 4.  The polycystic ovary syndrome.

Authors:  S S Yen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

Review 5.  Polycystic ovarian disease.

Authors:  J W Goldzieher
Journal:  Fertil Steril       Date:  1981-04       Impact factor: 7.329

6.  Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticosteroids.

Authors:  E R Simpson; G E Ackerman; M E Smith; C R Mendelson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

7.  Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries.

Authors:  G F Erickson; A J Hsueh; M E Quigley; R W Rebar; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1979-10       Impact factor: 5.958

8.  Endocrine studies of normal and polycystic ovarian tissues in vitro.

Authors:  E A Wilson; G F Erickson; P Zarutski; A E Finn; D Tulchinsky; K J Ryan
Journal:  Am J Obstet Gynecol       Date:  1979-05-01       Impact factor: 8.661

9.  The effects of growth factors and phorbol esters on steroid biosynthesis in isolated human theca interna and granulosa-lutein cells in long term culture.

Authors:  J M McAllister; W Byrd; E R Simpson
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

10.  Theca function in polycystic ovaries of a patient with virilizing congenital adrenal hyperplasia.

Authors:  G F Erickson; D A Magoffin; K L Jones
Journal:  Fertil Steril       Date:  1989-01       Impact factor: 7.329

View more
  3 in total

1.  miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.

Authors:  Jan M McAllister; Angela X Han; Bhavi P Modi; Maria E Teves; Grace R Mavodza; Zachary L Anderson; Tsaiwei Shen; Lane K Christenson; Kellie J Archer; Jerome F Strauss
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

2.  Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome.

Authors:  Jessica K Wickenheisser; Jessica M Biegler; Velen L Nelson-Degrave; Richard S Legro; Jerome F Strauss; Jan M McAllister
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

3.  Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10.

Authors:  Rishi Man Chugh; Hang-Soo Park; Abdeljabar El Andaloussi; Amro Elsharoud; Sahar Esfandyari; Mara Ulin; Lale Bakir; Alshimaa Aboalsoud; Mohamed Ali; Dalia Ashour; Prosper Igboeli; Nahed Ismail; Jan McAllister; Ayman Al-Hendy
Journal:  Stem Cell Res Ther       Date:  2021-07-07       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.